Price movement over the last 24 hours
ACADIA Pharmaceuticals Inc. vs Capri Holdings Ltd — how do they compare? ACADIA Pharmaceuticals Inc. trades at $25.99 (market cap $4.49B), while Capri Holdings Ltd trades at $17.91 (market cap $2.23B). The key difference: ACADIA Pharmaceuticals Inc. is far larger — about 2× Capri Holdings Ltd's market cap, and ACADIA Pharmaceuticals Inc. is trading nearer its 52-week high, Capri Holdings Ltd nearer its low. Which is the better fit depends on your goals.
| ACAD | CPRI | |
|---|---|---|
Market Cap | $4.49B | $2.23B |
Sector | Health | Consumer Staples |
52-Week High | $28.06 | $27.66 |
52-Week Low | $20.06 | $16.79 |
Enterprise Value | $3.69B | $3.51B |
Trailing returns across standard periods
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Michael Kors, Versace, and Jimmy Choo are the brands of Capri Holdings, a marketer, distributor, and retailer of upscale accessories and apparel. Kors, Capri's largest brand, offers handbags, footwear, and apparel through more than 800 company-owned stores, wholesale, and e-commerce. Versace (acquired in 2018) is known for its ready-to-wear luxury fashion, while Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. John Idol has served as CEO since 2003.
Read more on CPRI →